I think your criticism is a bit harsh. This product is different to say mining. Don't forget, trials have been repeated because not the right data was collected and that's on the previous ceo. Then finding the perfect set of patients for the current trials can be difficult and not that straight forward. Hence the days. However there should not be any further delays for the interim results.The cash raising could have been done better but there is now enough cash to get past the next milestone. If those results are positive then the sp should sky rocket and we either entertain a big pharma for a merge or takeover or go alone.We just have to wait until q3.Imho & dyor
I think your criticism is a bit harsh. This product is different...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $66.72M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.0¢ | $130.5K | 6.267M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 5403455 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 1035727 | 1 |
View Market Depth
| Last trade - 15.16pm 26/06/2025 (20 minute delay) ? |
| ACW (ASX) Chart |